Your browser doesn't support javascript.
loading
Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2.
Kernt, Marcus; Thiele, Sarah; Neubauer, Aljoscha S; Koenig, Susanna; Hirneiss, Christoph; Haritoglou, Christos; Ulbig, Michael W; Kampik, Anselm.
Affiliation
  • Kernt M; Department of Ophthalmology, Ludwig Maximilian University, Munich, Germany. marcus.kernt@med.uni-muenchen.de
Retina ; 32(8): 1652-63, 2012 Sep.
Article in En | MEDLINE | ID: mdl-22466477
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet-Derived Growth Factor / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor / Neuropilins / Vascular Endothelial Growth Factor A / Protein Kinase Inhibitors / Retinal Pigment Epithelium Language: En Journal: Retina Year: 2012 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Platelet-Derived Growth Factor / Angiogenesis Inhibitors / Receptors, Vascular Endothelial Growth Factor / Neuropilins / Vascular Endothelial Growth Factor A / Protein Kinase Inhibitors / Retinal Pigment Epithelium Language: En Journal: Retina Year: 2012 Document type: Article Affiliation country: Country of publication: